📘 The #IASEdFund 2025 summary report is out! Explore key moments from last year’s activities: zurl.co/oxFtF
📽️ Missed the 2025 meetings in #Mozambique, #Togo & #Thailand? Watch the recordings on #IASPlus: zurl.co/nJB4U
#RethinkRebuildRise #HIV #IAS2025
" #Lenacapavir: Everything you need to know about the new #HIV prevention drug"
#IAS2025 #RethinkRebuildRise
"An Inside Look at #IAS2025: Read the Conference Report" via @pozmagazine.bsky.social
🌐 #IAS2025 showed even amid an unprecedented funding crisis, the #HIV response remains resilient, innovative & united.
Nearly 4,000 people joined in #Kigali & virtually, with strong participation from across Africa.
🔎Explore the IAS 2025 conference report: zurl.co/mdpzv
#RethinkRebuildRise
"I had the privilege of attending the International AIDS Society 2025 Conference on #HIV Science in Kigali, Rwanda...the overall tone of the meeting was resilience in the face of adversity"
- Brian Conway, via @vancouversun.bsky.social
#IAS2025 #RethinkRebuildRise
In recognition of #WorldAIDSDay, in JIAS, Sara M. Allinder and her co-authors outline key advocacy priorities identified through a global consultation launched by the Road to Rio initiative, building on the momentum of the Kigali Declaration at #IAS2025. onlinelibrary.wiley.com/doi/10.1002/...
In 2025 the White Coat Campaign was used during the #FfD4 and #IAS2025 to highlight the need for continued investment in global healthcare.
World AIDS day is a time for remembrance, reflection and action.
🌍 How can we strengthen #HIV prevention in a rapidly changing global landscape?
📲 Watch the #IAS2025 plenary session “Getting to grips with prevention” – now available on demand on #IASPlus!
The #IAS2025 session “The double burden: #HIV incidence and prevalence in #conflict” brought together leading experts to examine evidence and strategies to sustain the HIV response in humanitarian settings.
▶️ Watch a free replay on #IASPlus now.
✨ Highlights from #IAS2025 ✨
Check out key takeaways in the Rapporteur report-back and closing session. Our rapporteurs provided insights across all major tracks – followed by an inspirational closing session.
🎥 Watch this session on #IASPlus now:
zurl.co/dmdVs
Our latest data presented at #IAS2025 tracks global policies harming migrants, students & workers living with #HIV.
Explore Positive Destinations www.positivedestinations.info/news/17928-g...
Starting to cull, compile, curate for the Virologic Assault exhibition in December. What's ✅ what's ❎ #WorldAIDSDay #VirologicAssault #artipodean #hivaids #IAS2025
In a recent blog, #IAS2025 scholarship recipient Heather Ellis shares her experience and key takeaways from #Kigali. 👇
"On the one hand, we’re witnessing extraordinary scientific breakthroughs that could transform prevention and treatment... On the other hand, these very advances are under threat from massive funding cuts...”
- IAS President Beatriz Grinsztejn, via @pozmagazine.bsky.social , #IAS2025
✊ " #IAS2025 reminded us that advocacy is not a relic of the past—it’s our most powerful tool for the future. The movement is alive."
- @jirairratevosian.bsky.social, via @pozmagazine.bsky.social
"Everyone can now view recorded sessions from the International AIDS Society Conference on HIV Science in July" via @pozmagazine.bsky.social #IAS2025
🚀 The #IAS2025 opening session set the stage for a powerful conference!
It featured IAS President Beatriz Grinsztejn, Jeanine Condo, Sabin Nsanzimana, Tedros Adhanom Ghebreyesus, Rosemary Mburuwaci & Linda-Gail Bekker.
🎥 Watch it now & over a hundred other sessions on #IASPlus:
zurl.co/UTLa3
✨ All session recordings from #IAS2025, the 13th IAS Conference on #HIV Science, are now available to everyone on #IASPlus!
▶️ Browse hundreds of hours of content, including e-posters, presentations on breaking science & expert discussions on the global #HIV response:
zurl.co/nQ0Mn
“What I have seen that’s really important from [ #IAS2025 ] is that ministries of health, people from countries, and programs are stepping up and taking ownership [of their #HIV response]”
- @drmegdoherty.bsky.social, via @thebodydotcom.bsky.social
🙋🏿 Looking for key takeaways from #IAS2025?
Our recent webinar explored scientific, policy, funding & community highlights from #Kigali.
The recording is now available in Arabic, English, French, Portuguese, Russian & Spanish.
🎥 Watch it on #IASPlus:
zurl.co/UEZQX
"At #IAS2025, in #Kigali, PURPOSE researchers showcased #lenacapavir... It delivered near-total protection across groups... But experts warned the next test lies not in the data but in the ability of health systems to turn science into access."
via @devex.com
FROM LONG ACTING TO A FUNCTIONAL CURE:
HIGHLIGHTS FROM IAS2025 in 'plain language
The 13th IAS Conference on HIV Science held in Rwanda in July.
READ THE ARTICLE IN POSITIVE LIVING
@napwha.bsky.social
#HIV #HIVcure #HIVtreatment #HIVwomen #ias2025
napwha.org.au/positive/fro...
🌍 "#IAS2025 heard of commendable bold political commitment from countries such as #Rwanda & #SouthAfrica, but a worrying trend of reduced focus elsewhere. The conference brought renewed calls for African ownership of HIV/AIDS responses." via @nature.com
New from Science Africa : Highlights from last week’s webinar, “Key messages from #IAS2025.”
news.scienceafrica.co.ke/long-acting-...
🤖 La inteligencia artificial podría revolucionar la atención y prevención del VIH 💡
Es clave trabajar en una tecnología inclusiva y justa para evitar sesgos y discriminaciones🌍💜
📲 Lee «La Noticia del Día» de gTt-VIH 🧡
🔗 gtt-vih.org/publicacione...
#VIH #IAS2025 #IA
HIV Science from IAS2025 Unpacked – WATCH
Special Guest: Dr Jillian Lau, HIV clinical researcher from Melbourne unpacks the science from #IAS2025 in plain language. Video edited from a webinar hosted by @poswomenvic.bsky.social @napwha.bsky.social
positivewomen.org.au/hivscience-i...
News from #IAS2025: HRF-10071, a novel HIV maturation inhibitor, showed good antiviral activity in a small Phase II study. If confirmed in larger trials, it could offer a new option for people with drug-resistant virus & it may have potential for long-acting treatment.
www.poz.com/article/hiv-...
News from #IAS2025: HRF-10071, a novel HIV maturation inhibitor, showed good antiviral activity in a small Phase II study. If confirmed in larger trials, it could offer a new option for people with drug-resistant virus & it may have potential for long-acting treatment.
www.poz.com/article/hiv-...
👏 A big thank you to our speakers Kenneth Ngure, Susan Shumba, Alexandra Calmy, Gaston Devisich & Doreen Moraa Moracha for joining us today for our webinar "Key messages from #IAS2025"!
📲 All IAS 2025 content will be available to the public on 19 September on #IASPlus: plus.iasociety.org
"It's not one size fits all when it comes to #HIV prevention and treatment"
IAS President-Elect Kenneth Ngure, Key messages from #IAS2025 webinar, #IASEdFund